Adverse events in baseline anticoagulant users and nonusers
| Baseline anticoagulant users | Baseline anticoagulant nonusers | |
| Subjects | 32 | 592 |
| Adverse events affecting ≥10% of baseline anticoagulant users | ||
| Cough | 6 (18.8) | 178 (30.1) |
| Upper respiratory tract infection | 6 (18.8) | 153 (25.8) |
| Diarrhoea | 8 (25.0) | 121 (20.4) |
| IPF | 8 (25.0) | 120 (20.3) |
| Nausea | 7 (21.9) | 91 (15.4) |
| Dyspnoea | 3 (9.4) | 127 (21.5) |
| Fatigue | 2 (6.3) | 117 (19.8) |
| Headache | 4 (12.5) | 116 (19.6) |
| Nasopharyngitis | 5 (15.6) | 110 (18.6) |
| Bronchitis | 5 (15.6) | 92 (15.5) |
| Peripheral oedema | 5 (15.6) | 50 (8.4) |
| Back pain | 4 (12.5) | 62 (10.5) |
| Constipation | 4 (12.5) | 69 (11.7) |
| Dizziness | 3 (9.4) | 68 (11.5) |
| Rash | 1 (3.1) | 65 (11.0) |
| Sinusitis | 2 (6.3) | 63 (10.6) |
| Additional adverse events of interest | ||
| Cardiac events | 2 (6.3) | 55 (9.3) |
| Bleeding | 1 (3.1) | 22 (3.7) |
Data are presented as n or n (%). IPF: idiopathic pulmonary fibrosis.